title: Limb remote ischemic postconditioning protects against focal ischemia in rats.
abstract: Remote ischemic postconditioning (RIP) refers to an ischemia conducted in a distant organ that protects against a prior ischemia in another organ. We tested whether RIP protects against focal ischemia in the rat brain. Stroke was generated by a permanent occlusion of the left distal middle cerebral artery combined with a 30-min occlusion of the bilateral common carotid arteries (CCA) in male rats. After CCA release, RIP was generated by three cycles of 15-min occlusion/15-min release of the left-hind femoral artery. The results showed that rapid RIP performed immediately after CCA release reduced infarction by 67% measured at 2 days after stroke. In addition, delayed RIP initiated as late as 3 h, but not 6 h, still robustly reduced infarction by 43% 2 days after stroke. RIP's protective effect was abolished by injecting the protein synthesis inhibitor, cycloheximide, and the afferent nerve blocker, capsaicin, suggesting that RIP blocks ischemic injury by modulating protein synthesis and nerve activity. Nevertheless, rapid RIP did not reduce infarction size 2 months after stroke while it ameliorated the outcome of the behavioral test. In conclusion, RIP attenuates brain injury after focal ischemia.
authors.affiliation: Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305-5327, USA.
authors.forename: Chuancheng
authors.initials: C
authors.lastname: Ren
authors.forename: Zhimin
authors.initials: Z
authors.lastname: Yan
authors.forename: Dingtai
authors.initials: D
authors.lastname: Wei
authors.forename: Xuwen
authors.initials: X
authors.lastname: Gao
authors.forename: Xiaoyuan
authors.initials: X
authors.lastname: Chen
authors.forename: Heng
authors.initials: H
authors.lastname: Zhao
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002545:Brain Ischemia / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control*; D002211:Capsaicin / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology; D003513:Cycloheximide / Q000494:pharmacology; D006614:Hindlimb / Q000098:blood supply*; D020244:Infarction, Middle Cerebral Artery / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control*; D007511:Ischemia; D008297:Male; D009048:Motor Skills; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D014176:Protein Biosynthesis / Q000187:drug effects / Q000502:physiology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D011500:Protein Synthesis Inhibitors; D003513:Cycloheximide; D002211:Capsaicin